WebJul 1, 2024 · Purpose of review: This article reviews recent randomised clinical trials on systemic treatment of oesophago-gastric cancers in the perioperative and metastatic setting. Recent findings: Adding nivolumab to first-line chemotherapy improved survival in patients with metastatic gastric/gastro-oesophageal junction/oesophageal adenocarcinoma with … WebMay 28, 2024 · Neo-AEGIS was designed as the first randomised controlled trial to address this question. Methods: 377 patients with cT 2-3 N 0-3 M 0 AEG were randomly assigned …
Perioperative chemotherapy with fluorouracil plus
WebApr 11, 2024 · Whether adenocarcinomas of the gastro-oesophageal junction should be treated with perioperative FLOT or with preoperative … WebFLOT is used to treat oesophageal cancer (gullet) and stomach cancer cancer. It is best to read this information with our general information about chemotherapy and the type of … darnley bay marine protected area
Cancers Free Full-Text Neoadjuvant Chemoradiotherapy versus ...
WebBackground: Locally advanced gastroesophageal junction adenocarcinoma (GEJ) is treated with either perioperative chemotherapy (CT) or preoperative radiochemotherapy … WebFLOT is used to treat oesophageal cancer (gullet) and stomach cancer cancer. It is best to read this information with our general information about chemotherapy and the type of cancer you have.. Your doctor will talk to you about this treatment and its possible side effects before you agree to have treatment.FLOT is named after the initials of the drugs … WebFeb 19, 2024 · This ASO perspective reviews the findings of a randomized placebo-controlled, clinical trial evaluating adjuvant nivolumab in esophageal or gastroesophageal junction carcinoma, reported recently by the Checkmate 577 investigators. The use of postoperative immunotherapy represents a significant paradigm shift for managing … bisnow executive team